RiverVest Venture Fund IV, L.P.'s Form 4 filing
Xilio Therapeutics, Inc.XLO · filed Oct 26, 2021
- Accession no.
- 0000899243-21-041580
- Filed
- Oct 26, 2021
- Trade date
- Oct 26, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $4.00M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| RiverVest Venture Fund IV, L.P.CIK 0001725443 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 26, 2021 | Common Stock | CConversionAcquired | +832,120 | –F1 | – | 832,120 | Indirect | |
| Oct 26, 2021 | Common Stock | CConversionAcquired | +359,324 | –F1 | – | 1,191,444 | Indirect | |
| Oct 26, 2021 | Common Stock | PPurchaseAcquired | +250,000 | $16.00 | +$4,000,000 | 1,441,444 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 26, 2021 | Common Stock | CConversionDisposed | −832,120 | $0.00 | $0 | 0 | Indirect | |
| Oct 26, 2021 | Common Stock | CConversionDisposed | −359,324 | $0.00 | $0 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into 1 share of the Issuer's common stock upon the closing of the Issuer's initial public offering on October 26, 2021. The shares have no expiration date.
Referenced by the price of 2 transactions in Table I.